Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 12, 2026

Sterling Infrastructure and Griffon have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
Sterling Infrastructure and Griffon have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – March 12, 2026 – Zacks Equity Research shares Sterling Infrastructure, Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Sterling Infrastructure earns Zacks Rank #1 (Strong Buy)

    60% confidence
  • More than half of consumers in Asia Pacific region are gearing up to travel internationally in the next few months

    60% confidence
  • Signed backlog, unsigned awards, and future phase opportunities give visibility into a pool of work approaching $4.5 billion

    60% confidence
  • Investors looking for infrastructure stock providing long-term upside exposure to AI data centers, reshoring, e-commerce should consider buying Sterling Infrastructure now

    60% confidence
  • Griffon Corporation earns Zacks Rank #5 (Strong Sell)

    60% confidence
  • It is likely best to look elsewhere right now for a stock to buy in March regarding Griffon

    60% confidence
  • Visa stock currently carries a Zacks Rank #3 (Hold)

    60% confidence
  • Five areas—AI data centers, semiconductor fabrication, manufacturing, e-commerce distribution centers, and power generation—could arguably become the growth engines of the entire U.S. economy

    60% confidence
  • Sterling Infrastructure is projected to grow revenue and earnings by 25% in 2026

    60% confidence

Data points we hold from this source

Visa Inc. · pe ratio forward23.12 ratio
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com
Sterling Infrastructure and Griffon have been highlighted as Zacks Bull and Bear of the Day — Source | Via News | ViaNews Market